naphthoquinones and Periodontal-Diseases

naphthoquinones has been researched along with Periodontal-Diseases* in 3 studies

Other Studies

3 other study(ies) available for naphthoquinones and Periodontal-Diseases

ArticleYear
Oral spray containing plant-derived compounds is effective against common oral pathogens.
    Archives of oral biology, 2018, Volume: 90

    Plant-derived compounds are a good source of therapeutic agents and inhibitors of inflammatory process. Dental caries, periodontal diseases and candidiasis are common oral infections caused by virulent biofilms. The objectives of this study were to develop oral spray containing plant-derived compounds; α-mangostin (α-MG) and/or lawsone methyl ether (2-methoxy-1,4-naphthoquinone) (LME) and determine its antimicrobial, anti-biofilm, and anti-inflammatory activities.. Oral spray formulations were prepared containing α-MG (5 mg/ml) and/or LME (250 μg/ml). Antimicrobial activity against Candida albicans, Streptococcus mutans, and Porphyromonas gingivalis and anti-biofilm formation activities were determined as well as cytotoxicity and anti-inflammatory effects.. The oral spray demonstrated antimicrobial activity against all three of the oral pathogens tested with stronger effects on C. albicans and S. mutans than P. gingivalis. The formulation containing α-MG (2.5 mg/ml) and LME (125 ug/ml) reduced growth of the microorganisms about 1-2 Log CFU/ml at 1-3 h and the killing effects were complete at 24 h. Based on biofilm assay, the oral spray containing both α-MG and LME showed greater inhibitory effects than those with α-MG or LME. In addition, the oral spray containing both α-MG and LME demonstrated more inhibition of nitric oxide production than α-MG alone. All the formulations were safe and demonstrated greater anti-inflammatory activity at lower concentration (<6.25 μg/ml) than at a higher concentration.. Oral spray containing α-MG and/or LME is effective against common oral pathogens without significant cytotoxicity. Thus, it has the potential to prevent the infections and may serve as adjunctive treatment to conventional therapy.

    Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Biofilms; Candida albicans; Candidiasis; Cell Survival; Colony Count, Microbial; Dental Caries; Mice; Microbial Sensitivity Tests; Naphthoquinones; Nitric Oxide; Oral Sprays; Periodontal Diseases; Phytochemicals; Plant Exudates; Porphyromonas gingivalis; RAW 264.7 Cells; Streptococcus mutans; Thailand; Xanthones

2018
Shikonin Inhibits Inflammatory Cytokine Production in Human Periodontal Ligament Cells.
    Inflammation, 2016, Volume: 39, Issue:3

    Shikonin, which is derived from Lithospermum erythrorhizon, a herb used in traditional medicine, has long been considered to be a useful treatment for various diseases in traditional oriental medicine. Shikonin has recently been reported to have several pharmacological properties, e.g., it has anti-microbial, anti-tumor, and anti-inflammatory effects. The aim of this study was to examine whether shikonin is able to influence the production of interleukin (IL)-6, IL-8, and/or chemokine C-C motif ligand (CCL)20, which contribute to the pathogenesis of periodontal disease, in human periodontal ligament cells (HPDLC). The production levels of IL-6, IL-8, and CCL20 in HPDLC were determined using an ELISA. Western blot analysis was used to detect nuclear factor kappa B (NF-κB) pathway activation in HPDLC. Shikonin prevented IL-1β- or tumor necrosis factor (TNF)-α-mediated IL-6, IL-8, and CCL20 production in HPDLC. Moreover, we found that shikonin suppressed the phosphorylation and degradation of inhibitor of kappa B-alpha (IκB-α) in IL-1β- or TNF-α-stimulated HPDLC. These findings suggest that shikonin could have direct beneficial effects against periodontal disease by reducing IL-6, IL-8, and CCL20 production in periodontal lesions.

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Chemokine CCL20; Cytokines; Humans; Inflammation; Interleukin-6; Interleukin-8; Naphthoquinones; Periodontal Diseases; Periodontal Ligament

2016
[Use of Yuglon in the complex treatment of parodontosis].
    Vrachebnoe delo, 1972, Volume: 5

    Topics: Adult; Anti-Inflammatory Agents; Humans; Middle Aged; Naphthoquinones; Periodontal Diseases

1972